#399 ‒ The evolution of Alzheimer’s disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.
Key claim: Gayatri Devi argues that early diagnosis of Alzheimer’s now meaningfully changes the trajectory of cognitive health via personalized treatment, new therapies, and a multimodal approach.
Abstract
"Early diagnosis really does make a difference now in terms of changing the trajectory of someone’s cognitive health.” —Gayatri Devi The post #399 ‒ The evolution of Alzheimer’s disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D. appeared first on Peter Attia MD.
Why this matters
Alzheimer’s care is a live front for the ‘personalized, multimodal, catch-it-early’ narrative that also drives precision geromedicine, and credentialed clinicians on major longevity podcasts are now carrying that message to lay audiences. Tracking this matters because the trend momentum — early screening, tailored regimens, new anti-amyloid therapies — is running ahead of the head-to-head outcome evidence for most of the individual components being bundled together.